Citigroup Inc Tela Bio, Inc. Transaction History
Citigroup Inc
- $196 Billion
- Q2 2025
A detailed history of Citigroup Inc transactions in Tela Bio, Inc. stock. As of the latest transaction made, Citigroup Inc holds 750,000 shares of TELA stock, worth $907,500. This represents 0.0% of its overall portfolio holdings.
Number of Shares
750,000
Previous 750,000
-0.0%
Holding current value
$907,500
Previous $915,000
59.02%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding TELA
# of Institutions
48Shares Held
23.7MCall Options Held
764KPut Options Held
0-
Nantahala Capital Management, LLC New Canaan, CT5.11MShares$6.19 Million0.43% of portfolio
-
Essex Woodlands Management, Inc. The Woodlands, TX4.11MShares$4.97 Million2.86% of portfolio
-
Silverarc Capital Management, LLC2.78MShares$3.36 Million1.3% of portfolio
-
Stonepine Capital Management, LLC Bend, OR2.08MShares$2.52 Million3.97% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.91MShares$2.31 Million0.0% of portfolio
About TELA Bio, Inc.
- Ticker TELA
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 19,157,600
- Market Cap $23.2M
- Description
- TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall recon...